Purchases and Sales Made in Q4 2022 in Ani Pharmaceuticals Inc (ANIP)
This table provides information about the institutional ownership of Ani Pharmaceuticals Inc (ANIP) during Q4 2022. The information is specifically focused on institutions that hold shares of ANI PHARMACEUTICALS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-19.6K- 16.25% |
$627K - $824K
|
101K
$6.92M
|
|
|
Feb 09, 2023
Q4 2022
|
William Blair Investment Management, LLC
Chicago, IL |
SELL
|
- |
-19.9K- 3.64% |
$636K - $836K
|
527K
$36.1M
|
|
|
May 14, 2024
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-20.2K- 21.85% |
$646K - $849K
|
72.4K
$4.95M
|
|
|
Feb 13, 2023
Q4 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-20.2K- 21.85% |
$646K - $849K
|
72.4K
$4.95M
|
|
|
Feb 14, 2023
Q4 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-25.2K- 48.65% |
$805K - $1.06M
|
26.6K
$1.82M
|